InsidersTradesSigma
Follow the MONTE ROSA THERAPEUTICS INC share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was disclosed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: FILIP JANKU. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
MONTE ROSA THERAPEUTICS INC is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases.